Physician Involvement in Procurement Is Essential for Optimal Patient Care
Innovation is essential for medicine's evolution, ensuring physicians treat patients with the best techniques and equipment available. While recognizing the fiscal constraints of our health care system, physicians must participate in the procurement process; cognizant and conscientious clinicians on the frontlines of patient care are ideally positioned to know what tools we need in our treatment arsenal [1] .
Interventional radiology is 1 of many specialties that may be adversely impacted by policies and procedures that curb innovation. Conditions that previously required lengthy incisions can now be treated via tiny skin nicks. Less invasive therapies ultimately reduce the financial burden to our health care system [1] with shorter hospital stays and quicker returns to work for patients, the latter an underestimated benefit. When discussing product purchases, policies are frequently constructed prioritizing the financial bottom line over effects on patient care, which can hinder new advances [2] .
For products such as syringes and standard wires, bulk purchasing makes sense to achieve lower upfront costs; even substantive changes to such commodity devices would not significantly change patient outcomes or reduce costs. However, new medical technologies may considerably alter patient management and costs; transparent processes for selecting innovative medical technologies are essential. Optimal patient care requires access to a range of medical devices; sole sourcing is risky especially in device-intensive specialties. Using penicillin to treat all infections is nonsensical and so is using the same stent in all vessels. Collaborative consultation between physicians and administrators can achieve both cost savings and excellent patient outcomes [3] . Purchase groups may be helpful once minimum standards and continuous assessment processes are established.
Once contracts are awarded for a particular medical technology, developments to similar devices cannot be adopted, stalling innovation. There is no incentive to price products competitively for contract durations. Responding to extensive requests for proposals also diverts funds from product research and development to bureaucracy. We recommend shortened contract durations and flexible request for proposal processes to facilitate rapid turnover of technologies, lower costs, and encourage competition.
It is incumbent on us as doctors to advocate for the best care of our patients. We must collaborate on decision-making procurement teams to ensure appropriate medical equipment and treatments are available and create policies and procedures that foster innovation. Physicians do not treat ''commodity'' disease states and should not be held hostage to commodity-type procurement processes.
